Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES HELLMAN & FRIEDMAN IN CONNECTION WITH THE ACQUISITION OF BAIN CAPITAL’S STAKE IN SECURITAS DIRECT VERISURE GROUP
Mandate

VINGE ADVISES HELLMAN & FRIEDMAN IN CONNECTION WITH THE ACQUISITION OF BAIN CAPITAL’S STAKE IN SECURITAS DIRECT VERISURE GROUP

October 05, 2015

Vinge and Latham & Watkins LLP have advised Hellman & Friedman in connection with the acquisition of Bain Capital’s stake in Securitas Direct Verisure Group. Verisure Securitas Direct is a leading supplier of professionally monitored home alarms, fire alarms and connected services for homes and businesses. The company’s 1.8 million customers are spread over 13 countries in Europe and South America. The transaction is subject to customary regulatory conditions and approvals.

Vinge’s team consisted of partner Jonas Bergström together with, among others, associates Linda Sengul and Carl Sander. Partner Louise Brorsson Salomon and associates Anders Morén and Linn Adelwald provided financing advice in relation to the transaction.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025